Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Takayasu phlebitis.
Katayama Y, Matsumoto Y, Yamamura Y, Asano Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J. Katayama Y, et al. Among authors: narazaki m. Rheumatology (Oxford). 2020 Dec 1;59(12):e131-e133. doi: 10.1093/rheumatology/keaa333. Rheumatology (Oxford). 2020. PMID: 32617559 No abstract available.
Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
Katsuyama E, Yan M, Watanabe KS, Narazaki M, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J. Katsuyama E, et al. Among authors: narazaki m. J Immunol. 2017 Jun 1;198(11):4268-4276. doi: 10.4049/jimmunol.1601705. Epub 2017 Apr 24. J Immunol. 2017. PMID: 28438897
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
Tatebe N, Sada KE, Asano Y, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Narazaki M, Watanabe K, Kawabata T, Wada J. Tatebe N, et al. Among authors: narazaki m. Mod Rheumatol. 2018 Jan;28(1):141-146. doi: 10.1080/14397595.2017.1317377. Epub 2017 May 2. Mod Rheumatol. 2018. PMID: 28463039 Free article.
Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy.
Katsuyama E, Wakabayashi H, Sada KE, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Narazaki M, Tatebe N, Sunahori-Watanabe K, Kawabata T, Wada J. Katsuyama E, et al. Among authors: narazaki m. Acta Med Okayama. 2017 Oct;71(5):445-448. doi: 10.18926/AMO/55444. Acta Med Okayama. 2017. PMID: 29042704 Free article.
Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J. Ohashi K, et al. Among authors: narazaki m. J Clin Rheumatol. 2019 Sep;25(6):246-251. doi: 10.1097/RHU.0000000000000836. J Clin Rheumatol. 2019. PMID: 29933322
Correction: Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
Katsuyama E, Yan M, Watanabe KS, Narazaki M, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J. Katsuyama E, et al. Among authors: narazaki m. J Immunol. 2018 Aug 1;201(3):1104. doi: 10.4049/jimmunol.1800810. Epub 2018 Jun 25. J Immunol. 2018. PMID: 29941662 No abstract available.
Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry.
Morishita M, Sada KE, Ohashi K, Miyawaki Y, Asano Y, Hayashi K, Asano SH, Yamamura Y, Watanabe H, Narazaki M, Matsumoto Y, Kawabata T, Yajima N, Wada J. Morishita M, et al. Among authors: narazaki m. Lupus. 2020 Feb;29(2):176-181. doi: 10.1177/0961203319898766. Epub 2020 Jan 10. Lupus. 2020. PMID: 31924143
144 results